RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Carlos A. Paladini to Piperazines

Back to Details
This is a "connection" page, showing publications Carlos A. Paladini has written about Piperazines.
Carlos A. Paladini
Connection Strength
0.197
Piperazines
  1. Mencacci C. Efficacy and tolerability of switching to ziprasidone in italian patients with acute exacerbation of schizophrenia: an open-label trial. Pharmacopsychiatry. 2012 Sep; 45(6):236-40.
    View in: PubMed
    Score: 0.197
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support